UPDATE: 14. January 2021: Ivermectin is Now a Treatment Option for Health Care Providers!

UPDATE 09. January 2021: South Africa Authorities are wiggling around while people die: Data on Ivermectin 'will soon be available': SAHPRA

UPDATE 07. January 2021: “Stop Covid-19 deaths, give us ivermectin Now!” – BLF


UPDATE 04. January 2020: Ivermectin: Tests show cheap drug may reduce Covid-19 death toll

ICYMI: IMPORTANT: Ivermectin And COVID-19: How Is It Proposed To Work? Review Of All Theorized Mechanisms Of Action + Antiviral Research Volume 178, June 2020: The FDA-approved drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro

Cheap hair lice drug may cut risk of COVID-19 death by 80 percent: study

By Hannah Sparks - 04. January 2021

A simple treatment for COVID-19 could be cheaper than 20 bucks — and familiar to most grade school nurses.

Head lice drug ivermectin is being explored as a potential treatment for the coronavirus following a promising new study that showed an 80% reduction in hospitalized COVID-19 patient deaths.

Just 8 out of 573 patients who received ivermectin passed away, compared to the 44 individuals out of 510 who died after being given a placebo.

An earlier study of the antiparasitic prescription drug, which costs between $17 and $43 for a course of treatment, according to GoodRx, revealed promising results in April — by removing all viral RNA within 48 hours of a single dose.

Liverpool University virologist Andrew Hill has called the new study “transformational” in the search for a coronavirus therapy. His findings, based on data from over 1,400 patients, were made public in a video posted to YouTubein which Hill discusses his results in a previously aired livestream. The research currently awaits peer review prior to publishing.

“If we see these same trends observed consistently across more studies, then this really is going to be a transformational treatment,” said Hill.

However, critics have called Hill’s study conclusion premature, urging further research before declaring ivermectin an effective treatment — citing other buzzed-about methods that ultimately failed to deliver, such as hydroxychloroquine and tocilizumab.

“All we have are observational studies and clinicians’ opinions,” said University of Sydney professor Andrew McLachlan, the Daily Mail reported.

“Many of the current studies have low numbers of participants, weak study designs, and inconsistent (and relatively low) ivermectin dosing regimes, with ivermectin frequently given in combination with other drugs.

Ivermectin Image AFP via Getty Images

SEE ALSO: Head lice drug ivermectin being studied as possible coronavirus treatment


Front Line COVID-19
Critical Care Alliance

NIH (National Institutes of Health) Revises Treatment Guidelines for Ivermectin for the Treatment of COVID-19

Ivermectin is Now a Treatment Option for Health Care Providers!

Jan 14, 2021 – One week after Dr. Paul Marik and Dr. Pierre Kory – founding members of the Front Line Covid-19 Critical Care Alliance (FLCCC) – along with Dr. Andrew Hill, researcher and consultant to the World Health Organization (WHO), presented their data before the NIH Treatment Guidelines Panel, the NIH has upgraded their recommen­da­tion and now considers Ivermectin an option for use in COVID-19.

Their recommendation has now been upgraded to the same level as those for widely used monoclonal antibodies & convalescent plasma, which is a “neither for nor against” recommen­da­tion. The significance of this change is that the NIH has decided to no longer recommend against the use of ivermectin in the treatment of COVID-19 by the nation’s health care providers. A consequence of this change is that ivermectin has now been made a clear therapeutic option for patients.

Read our  Press Release (Jan 15, 2021).


 FLCCC Alliance Response to the NIH Guideline Committee Recommendation on Ivermectin use in COVID-19 dated January 14th, 2021

Dr. Pierre Kory testifies to Senate Committee about Ivermectin, Dec. 8, 2020

Appearing as a witness on Dec. 8, 2020, before the Senate Committee on Homeland Security and Governmental Affairs—which held a hearing on “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution”— Dr. Pierre Kory, President of the Frontline COVID-19 Critical Care Alliance (FLCCC), called for the government to swiftly review the already expansive and still rapidly emerging medical evidence on Ivermectin. Read More

Jan 7, 2021 – Press Release
 FLCCC Alliance Invited to the NIH COVID-19 Treatment Guidelines Panel to Present Latest Data on Ivermectin
On January 6, 2021, our Drs. Pierre Kory and Paul Marik, founding members of the FLCCC Alliance, appeared before the National Institutes of Health COVID-19 Treatment Guidelines Panel to urge review of current data and an updated NIH guidance.

Dec 15, 2020 – now published:
 Clinical and Scientific Rationale for the “MATH+” Hospital Treatment Protocol for COVID-19
FLCCC Alliance peer-reviewed paper published in the Journal of Intensive Care Medicine. The protocol described in this paper potentially offers a life-saving approach to the management of hospitalized COVID-19 patients. The MATH+ protocol offers an inexpensive combination of medicines with well-known safety profiles based on strong physiologic rationale and an increasing clinical evidence base.

“The I-MASK+ protocol will revolutionize the treatment of COVID-19”

Dr. Paul Marik (Oct. 30, 2020)

The Front Line COVID-19 Critical Care Alliance has now developed a prophylactic and early outpatient combination treatment protocol for COVID-19 called I-Mask+. This protocol is centered around the use of ivermectin, a well-known anti-parasite drug. Ivermectin has recently discovered anti-viral and anti-inflammatory properties and a rapidly growing published medical evidence base demonstrating its unique and highly potent ability to inhibit SARS-CoV-2 replication.

Please visit these links to get the full picture:

In March, 2020 we first published our MATH+ Treatment Protocol for COVID-19, intended for hospitalized patients. The recently developed I-MASK+ Prophylaxis & Early Outpatient Treatment Protocol for COVID-19 is instead directed for use as a prophylaxis and in early outpatient treatment after contracting COVID-19. The protocols thus complement each other, and both are physiologic-based combination treatment regimens developed by leaders in critical care medicine. All component medicines are FDA-approved, inexpensive, readily available and have been used for decades with well-established safety profiles.


PROLOGUE: Obviously the Powers That Be in South Africa and their "authorities" are firmly in the grip of BigPharma, the Vaccine Mafia around Bill Gates, the IMF as well as the WorldBank and their WEF / Rockefeller masterminds. The Hunger Games are already on in large parts of the country and when this time the oppressed will really stand up, the long deserved freedom from colonial and neoliberal oppression will wipe all the present structures from the face of the Earth in South Africa. It would be a very bloody uprising, which only can be averted if president Cyril Ramaphosa makes a 180 degree turn and for the first time really puts the people first.

Data on Ivermectin 'will soon be available': SAHPRA

By SABC Radio - 09 January 2021

Image: Reuters

SAHPRA Chairperson Professor Helen Rees has pleaded with the public and doctors not to distribute or take Ivermectin until its safety and efficacy are verified

The South African Health Regulatory Authority (SAHPRA) says data on the effectiveness of Ivermectin in the treatment or prevention of COVID-19 is expected to be available in a few weeks’ time.

Ivermectin is registered with SAHPRA for use in the treatment of animals.

There’s a growing illegal distribution of the drug following reports that it is effective in combating COVID-19. Some medical experts, along with the National Freedom Party, are lobbying for the drug to be approved for use in humans.

SAHPRA Chairperson Professor Helen Rees has pleaded with the public and doctors not to distribute or take the drug until its safety and efficacy are verified.

“There needs to be more clinical trial data. There are some better-designed large trials that are under way in South America and we are hoping to get some of these results in the next few weeks. Nobody,  including the World Health Organisation and other regulatory authorities, nobody is currently recommending its use for treatment or prevention. If people are giving it, nobody would know even what dose to give, so it’s very easy to overdose. What we would plead is in a few more weeks we will have more definitive data if people can be patient with us and we will be able to have a definitive answer,” says Rees.

SAHPRA says more clinical trials must be conducted before Ivermectin can be used to treat COVID-19

SA to get first batch of vaccine in January

On Thursday, Health Minister Zweli Mkhize told Parliament’s Portfolio Committee on Health that the country would receive the first batch of vaccine in January and another in February.

He says that priority will be given to the more than one million health workers in both the private and the public sectors.

On Friday, the Department of Health confirmed 21 980 new coronavirus infections, taking the total number to 1 192 570.

The country has also recorded 616 new COVID-19 related fatalities on Friday.

In a statement, Health Minister Dr Zweli Mkhize says most of the new deaths were recorded in the Eastern Cape.

DISCUSSION: South Africa’s COVID-19 vaccine rollout strategy

Read More: Bail bid for man arrested at Durban airport for trying to smuggle Ivermectin tablets




“Stop Covid-19 deaths, give us ivermectin Now!” – BLF

By BLF - 


The government of Cyril Ramaphosa is killing South Africans for profits. The government knows that there is a cheap safe and affordable medicine against the deadly Covid-19 virus. The medicine to defeat Covid-19 which originates from Japan and is widely used the world-over, is called ivermectin.

Research shows that ivermectin can kill SARS-CoV-2, which is the virus causing the COVID-19 pandemic, within 2 days. The South African government is pushing Covid-19 vaccines because these will enrich the friends of President Ramaphosa who are also his donors. It is clear that the strategy is to get as many people as possible killed by Covid-19 so that the nation is driven into a panic acceptance of the Covid-19 vaccines.

Black First Land First (BLF) suspects that the South African Health Products Regulatory Authority (SAHPRA) is complicit with the government in creating panic through death to force-feed the nation Covid-19 vaccines. Why is SAHPRA not clearing ivermectin so that our people’s lives are saved. The spokesperson of SAHPRA is openly lying about the clinical clearance of ivermectin, which is described by doctors who prescribe it as a wonder medicine.

BLF calls on the Minister of Health, Dr Mkhize, to stop the expensive and unsafe Covid-19 vaccines and rather immediately make ivermectin available to our people. It is cheap and safe. We also call on SAHPRA to immediately clear ivermectin to be used in SA.

BLF is opposed to the Covid-19 vaccines. There are safer, cheaper and effective ways to fight Covid-19. These are blocked because of profits.

BLF is in consultation with a variety of stakeholders to launch a campaign against the Covid-19 vaccines. We say NO to Covid-19 vaccines, and YES to ivermectin!

Issued by Black First Land First, National Coordinating Committee of (BLF NCC)
07 January 2021

Contact Details

Black First Land First Mail: 

Zanele Lwana
(BLF Deputy President)
Cell: +27 79 986 7225
Reposted from the BLF website.



First published on BITCHUTE January 5th, 2021.

channel image

Knowledge And Truth TV

Ivermectin is an approved and inexpensive anti-parasitic drug known to be effective against a variety of viruses like Influenza, Dengue, Zika, and Covid-19.

Dr. Pierre Kory, a pulmonary and critical care specialist, passionately testified before the Senate Committee on Homeland Security and Governmental Affairs during a hearing on "Early Outpatient Treatment: An Essential Part of a COVID-19 Solution."

In his testimony, Kory said data shows the ability of ivermectin to prevent COVID-19, as well as its ability to keep those with early symptoms from progressing to the hyper-inflammatory phase of the disease, and to help critically ill patients


Ivermectin: Tests show cheap drug may reduce Covid-19 death toll

By Tom Whipple - 04 

Ivermectin cut deaths by 80 per cent among patients in hospital, according to a leaked presentation

Ivermectin cut deaths by 80 per cent among patients in hospital, according to a leaked presentation GETTY IMAGES

A cheap and widespread drug has shown the potential for “transformative” changes in Covid-19 mortality rates, according to an early analysis.

A leaked presentation from a closed scientific meeting claims that ivermectin, originally an antiparasitic, cut deaths by 80 per cent among patients in hospital. The findings come from the combined results of 11 trials.


Tom Whipple, The Times Science Editor

READ MORE: UK scientists worried vaccines may not work on SA Covid-19 variant


Ivermectin And COVID-19: How Is It Proposed To Work? Review Of All Theorized Mechanisms Of Action.

•Premiered Nov 1, 2020

Whiteboard Doctor

In this video we will discuss Ivermectin and it's proposed efficacy for both prophylaxis and treatment of COVID-19.

We will focus in this video on reviewing the proposed, theorized, and studied mechanisms of action to date.

The IMP alpha/beta pathway, the direct inhibition of the viral RNA dependent RNA Polymerase, CD147 Receptor inhibition, and STAT3 pathway manipulation. We will discuss how these mechanisms of action relate to the study findings including the potential efficacy for prophylaxis, post-exposure prophylaxis, early mild disease, and late severe disease. Check out the video for all the details! We have covered these mechanisms in depth in a number of previous videos, which are linked below if you are interested in more information!

SHAREABLE PLAYLIST WITH ALL OF OUR IVERMECTIN VIDEOS TO DATE: https://www.youtube.com/playlist?list...

Ivermectin, Azithromycin, Vitamin D Combination Therapy For Early, Outpatient COVID-19: New Study! https://www.youtube.com/watch?v=_4UWnxUrE7I

Ivermectin Videos: Ivermectin, Azithromycin, And Vitamin D Early Outpatient COVID-19: https://www.youtube.com/watch?v=_4UWn...

Ivermectin And The STAT3 Pathway: A New Mechanism Of Action: https://www.youtube.com/watch?v=cJHPM...

Randomized, Double Blinded Placebo Controlled Trial IVM+Doxycycline: https://www.youtube.com/watch?v=5MNsM...

IDEA Trial (Ivermectin, Dexamethasone, Enoxaparin, Aspirin) Mild, Mod, Sever COVID: https://www.youtube.com/watch?v=hX14o...

Ivermectin to Treat Hospitalized Patients with COVID-19: https://www.youtube.com/watch?v=_UvZH... I

VERCAR (Ivermectin and Carrageenan Prophylaxis): https://www.youtube.com/watch?v=TaPhp...

Ivermectin Inhibits RNA Dependent RNA Polymerase https://www.youtube.com/watch?v=1iRqT...

Ivermectin Post-Exposure Prophylaxis: https://www.youtube.com/watch?v=nJyyI...

Ivermectin Prophylaxis For COVID-19: https://www.youtube.com/watch?v=TmzvD... I

vermectin and Doxycycline To Treat Mild to Moderate COVID-19: https://www.youtube.com/watch?v=2LjIM...

Ivermectin, Hydroxychloroquine, and Azithromycin for Hospitalized COVID-19 patients: https://www.youtube.com/watch?v=UPWJ9...

Ivermectin and new mechanism; halting thrombi through inhibition of CD147: https://www.youtube.com/watch?v=l3yw1...

ICON Trial: https://www.youtube.com/watch?v=ryWck...

Clinical Trial on Ivermectin (data may be falsified): https://www.youtube.com/watch?v=8Z1Oc...

In Vitro on Ivermectin for COVID-19, 99.99% Decrease in Viral Load: https://www.youtube.com/watch?v=npcuI...

Ivermectin+Doxycyline Compared to Hydroxychloroquine+Azithromycin for COVID-19: https://www.youtube.com/watch?v=V2M-x...



Treatment of Covid-19

COVID-19 – The Fight for a Cure

Malaria drug only for certain COVID patients deadly



A Good Health Solution

Suggested Cure For 2019-nCoV/R Coronavirus

Andreas Kalcker reveals the REVOLUTION in medicine that humanity needs right now: ClO2


The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

Antiviral Research Volume 178, June 2020,



Ivermectin is an inhibitor of the COVID-19 causative virus (SARS-CoV-2) in vitro.

A single treatment able to effect ~5000-fold reduction in virus at 48 h in cell culture.

Ivermectin is FDA-approved for parasitic infections, and therefore has a potential for repurposing.

Ivermectin is widely available, due to its inclusion on the WHO model list of essential medicines.”

I have been waiting to hear more about this since running across the above last year. I guess we can’t have the above average flu suddenly thwarted by a track record therapy. No, in the pursuit of Science, we need data on the latest and greatest. Our need is so great, large scale trials with indemnity shall be the public’s duty. Pay no attention to the cure behind the curtain, I am the great and powerful mRNA!